Multicenter

3 trials

Sponsors

Eli Lilly, Antonius Ziekenhuis, Sneek

Conditions

Axial Spondyloarthritis Chronic Inflammatory disease affecting the spine and sacroiliac joint.disease causing swollen and painful joints Psoriatic arthritisknee stability

Phase 3

A 52-Week Multicenter, Randomized, Open-Label, Parallel-Group Study Evaluating the Efficacy and Safety of Ixekizumab versus Adalimumab in Patients with Psoriatic Arthritis Who Are Biologic Disease-Modifying Anti-Rheumatic Drug Naive

Active, not recruitingNL-OMON45393

Eli Lillydisease causing swollen and painful joints Psoriatic arthritis

Start: 2018-01-30Target: 4Updated: 2024-02-28

A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients with Axial Spondyloarthritis

Active, not recruitingNL-OMON47213

Eli LillyAxial Spondyloarthritis Chronic Inflammatory disease affecting the spine and sacroiliac joint.

Start: 2018-03-08Target: 7Updated: 2024-02-28

Unknown Phase

Performance of MRK, NexGen and LCS Total Knee Prosthesis based on AP Stability Measurement and PROMS

Active, not recruitingNL-OMON46917

Antonius Ziekenhuis, Sneekknee stability

Start: 2015-12-10Target: 180Updated: 2024-02-28